Unilever is a diversified beauty, well-being, and personal care (51% of 2025 sales by value), homecare (23%), and packaged food (26%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.
Last trade$65.69
Day change-$1.125 (-1.68%)
Day range$65.58 – $67.05
Volume2,402,011
Market cap$143.87B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for UL.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for UL.
Recent news
Company coverage with links to the original publishers.
The article compares e.l.f. Beauty and lululemon athletica as investment options for 2027. e.l.f. Beauty is highlighted as a high-growth cosmetics disruptor with 24.6% revenue growth and 31 consecutive quarters of sales increases, though it carries a high P/E ratio of 82.65. Lululemon athletica is presented as a more established, profitable player with a 14.2% net margin and lower valuation (P/E of 8.81), but faces slower 4.9% growth and business pressures. The analyst recommends e.l.f. Beauty for its sustained growth momentum despite higher valuation.
Consumer staples companies PepsiCo, McCormick, Hormel, and Clorox are trading near 52-week lows due to headwinds including changing consumer preferences toward healthier products, budget constraints, and rising costs. However, these companies offer attractive dividend yields (4.1%-5.7%) and have proven track records as dividend growers, making them potentially opportunistic buys for long-term dividend investors.
AXIL Brands has outperformed its sub-industry despite a challenging first quarter with 11.2% revenue decline. The newly launched XCOR II earbuds show promise with $3.6 million in initial orders, while improved liquidity ($7.9 million cash, no debt) and a discounted valuation (9.54X EV/EBITDA) provide support. However, analysts recommend holding rather than buying, citing the need for sustained demand demonstration and recurring cash generation before confirming a durable recovery.
The author argues that most investors misunderstand the stock market by focusing on short-term price movements rather than long-term business value. He explains Benjamin Graham's concept of the stock market as a 'voting machine' in the short term (driven by emotions) and a 'weighing machine' in the long term (reflecting true value). Taking advantage of current market pessimism, the author has doubled his position in McCormick, a well-run consumer staples company with a 4% dividend yield, believing Wall Street is undervaluing it despite solid fundamentals and a planned acquisition of Unilever's food business.
The author recommends two high-yield dividend stocks for October: Medtronic (MDT), which has completed a business overhaul and is approaching Dividend King status with a 3.3% yield, and McCormick (MKC), a consumer staples company with 39 years of dividend increases and a 4.2% yield that is acquiring Unilever's food business to roughly double its sales.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Nov 13, 2026
$0.5219
Dec 18, 2026
recurring
Aug 7, 2026
$0.5305
Sep 18, 2026
recurring
May 15, 2026
$0.5449
Jun 26, 2026
recurring
Feb 27, 2026
$0.5547
Apr 10, 2026
recurring
Nov 7, 2025
$0.5915
Dec 5, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.